It targets the brain regions responsible for appetite control, leading to a reduction in food intake
While its not possible to target belly fat exclusively through semaglutide GLP-1 treatment, many patients have reported a significant reduction in abdominal fat as a positive benefit of the medication
When beginning semaglutide treatment, its normal to have many questions
If side effects persist or become bothersome, it is important to speak with your healthcare provider
By combining all three receptor targets, Retatrutide allows researchers to study the convergence of incretin biology and glucagon-driven energy expenditure in a single compound, opening research questions that cannot be addressed with any dual or single-receptor agonist
With Mounjaro, the medication may remain in the stomach for a longer period